{"schema_version":"1","generated_at":"2026-10-29T06:06:14.382Z","data_as_of":null,"url":"https://www.findmykol.com/kol/anna-halpern","json_url":"https://www.findmykol.com/kol/anna-halpern/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"anna-halpern","name":"Anna Halpern","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"University of Washington","institution_url":"https://www.findmykol.com/institution/university-of-washington","city":"Seattle","state":"WA","region":{"label":"West","url":"https://www.findmykol.com/region/west"}},"identifiers":{"npi":"1952531790","orcid":"0000-0002-4326-0748","openalex":"A5086909430"},"summary":"Anna Halpern is an Oncology physician affiliated with University of Washington. OpenAlex indexes 178 publications with 1,602 citations (h-index 17); ClinicalTrials.gov lists 7 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":178,"cited_by_count":1602,"h_index":17,"latest_activity_year":2025,"source":"works"},"trials":{"count":7,"shown":3,"withheld":4,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT07148947","title":"Pacritinib With Standard of Care Azacitidine or Decitabine as a Bridge to Allogeneic Hematopoietic Stem Cell Transplant for Patients With Accelerated and Blast Phase Myeloproliferative Neoplasms","phase":"PHASE2","status":"RECRUITING","role":"Overall official","sponsor":"University of Washington","source_url":"https://clinicaltrials.gov/study/NCT07148947","trial_url":"https://www.findmykol.com/trial/NCT07148947"},{"nct":"NCT06710418","title":"Evaluating the Effects of Hemoglobin Threshold-specific Packed Red Blood Cell Transfusions on Quality of Life and Functional Outcomes in Patients With High-grade Myeloid Neoplasms, Acute Myeloid Leukemia, or B Acute Lymphoblastic Lymphoma/Leukemia","phase":"NA","status":"RECRUITING","role":"Overall official","sponsor":"University of Washington","source_url":"https://clinicaltrials.gov/study/NCT06710418","trial_url":"https://www.findmykol.com/trial/NCT06710418"},{"nct":"NCT04282187","title":"Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms","phase":"PHASE2","status":"RECRUITING","role":"Overall official","sponsor":"University of Washington","source_url":"https://clinicaltrials.gov/study/NCT04282187","trial_url":"https://www.findmykol.com/trial/NCT04282187"}],"source":"trials"},"payments":{"company_count":8,"program_years":{"first":2021,"last":null},"rows_total":9,"shown":3,"withheld":6,"rows":[{"payer":"SOBI, INC","program_year":2025,"amount_usd":3884.93,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1952531790"},{"payer":"Karyopharm Therapeutics Inc.","program_year":2025,"amount_usd":1700,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1952531790"},{"payer":"E.R. Squibb & Sons, L.L.C.","program_year":2025,"amount_usd":955,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1952531790"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1952531790","source":"payments"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Distal gut colonization by oral bacteria during intensive chemotherapy: direct evidence from strain-level analysis of paired samples","year":2025,"journal":"npj Biofilms and Microbiomes","source_url":"https://doi.org/10.1038/s41522-025-00725-7","status":"verified"},{"title":"A multicenter study to assess efficacy, safety, and tolerability of ropeginterferon alfa-2b-njft in patients with essential thrombocythemia in the US and Canada: EXCEED-ET trial","year":2025,"journal":"Frontiers in Medicine","source_url":"https://doi.org/10.3389/fmed.2025.1548590","status":"verified"},{"title":"A Phase 1b Study of DISC-0974, an Anti-Hemojuvelin Antibody, in Patients with Myelofibrosis and Anemia","year":2024,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2024-203719","status":"verified"},{"title":"Dose-Adjusted EPOCH Plus Inotuzumab Ozogamicin in Adults With Relapsed or Refractory B-Cell ALL","year":2024,"journal":"JAMA Oncology","source_url":"https://doi.org/10.1001/jamaoncol.2024.0967","status":"verified"},{"title":"Time independent factors that predict relapse in adults with acute myeloid leukemia","year":2024,"journal":"Blood Cancer Journal","source_url":"https://doi.org/10.1038/s41408-023-00954-z","status":"verified"}],"source":"works"},"contact":{"address_1":"825 EASTLAKE AVE E","city":"Seattle","state":"WA","zip":"981094405","phone":"206-288-1000","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1952531790","source":"identity"},"similar":[{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Connie Celum","slug":"connie-celum","institution":"University of Washington","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/connie-celum","json_url":"https://www.findmykol.com/kol/connie-celum/profile.json"},{"name":"Helen Chu","slug":"helen-chu","institution":"University of Washington","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/helen-chu","json_url":"https://www.findmykol.com/kol/helen-chu/profile.json"},{"name":"Bryan Kestenbaum","slug":"bryan-kestenbaum","institution":"University of Washington","specialty":"Nephrology","url":"https://www.findmykol.com/kol/bryan-kestenbaum","json_url":"https://www.findmykol.com/kol/bryan-kestenbaum/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":4,"payments":6,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2016-10-03","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}